ALSUntangled No. 54: “LEAP2BFIT”

Journal article

Peer reviewed

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, Vol.21(3-4)

2020

PMID: 32202161

Metrics

2 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.52 Neurodegenerative Diseases; 1.52.765 ALS Mechanisms
Web Of Science research areas: Clinical Neurology
ESI research areas: Neuroscience & Behavior

This output has contributed to the advancement of the following goals:

Source: InCites

Title: ALSUntangled No. 54: “LEAP2BFIT”
Creators: Michael Benatar - UMMG Department of Neurology
Publication Details: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, Vol.21(3-4)
Publisher: TAYLOR & FRANCIS LTD; 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
Grant note: ALS Association
ALSUntangled is sponsored by the ALS Association. Richard Bedlack has research support from ALSA and Orion, and consulting support from ALSA, Biogen, Brainstorm Cell, ITF Pharma, Mallinkrodt, New Biotic and Woolsey Pharma. Paul Wicks is employed by Wicks Digital Health Ltd, which has received funding from Ada Health, Baillie Gifford, Compass Pathways, Coronna, EIT, Happify, HealthUnlocked, Inbeeo, Sano Genetics, Self Care Catalysts, and The Learning Corp. PW is an associate editor at the Journal of Medical Internet Research and is on the editorial advisory boards of The BMJ, BMC Medicine, The Patient, and Digital Biomarkers.
Academic Unit: Miller School of Medicine; UMMG Department of Neurology; UMMG Dept of Neurology - Neuromuscular Disorders Div
Language: English
Resource Type: Journal article
PMID: 32202161
Record Identifier: 991032830846302976